State Ledger
Company profile

BIOVIE INC. CIK 1580149

Tickers
BIVI (Nasdaq) · BIVIW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Carson City, NV 89703
Fiscal year end
2026 (FY)
Market Data
Close
$1.34
Change
-$0.06
Change %
-3.94%
Volume
2,943

BIVI · trading date Oct 12, 2026 · previous close $1.40 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$22.07M
Total assets
$14.25M
Total liabilities
$3.98M
Stockholders' equity
$10.27M
Cash & equivalents
$8.98M
Operating income
-$22.65M
Operating cash flow
-$19.02M
Capital expenditures
—

Fiscal year 2026, via 10-K filed 2026-08-13. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
27.9%
Equity / assets
72.1%
CapEx / revenue
—
Operating cash flow / net income
0.86×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 — -$22.07M $14.25M $3.98M $10.27M
2025 — -$17.54M $21.56M $2.55M $19.01M
2024 — -$32.12M $25.21M $9.70M $15.51M
2023 — -$50.26M $35.10M $19.76M $15.34M
2022 — -$26.08M $20.11M $16.44M $3.67M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-08-13

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Carson City, NV 89703
680 W NYE LANE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Nevada — Public Companies